THURSDAY DECEMBER 11, 2025 |
||
| SATTELITE SYMPOSIUM JOHNSON & JOHNSON Innovation in IBD Care: IL-23 Inhibition in Dutch Clinical Practice |
||
| Speakers: Sander van Deventer, MD, PhD - Operating Partner Forbion Capital Partners Professor Carsten Schmidt, MD, PhD - Gastroenterologist, Fulda Clinic, Germany Matthijs Versteegh, PhD - Health Economics Researcher I Huygens & Versteegh |
||
| PROGRAM | ||
| 12.15-12.25 | Opening and introduction | |
| 12.25-12.45 | Clinical Program and the German Experience | |
| 12.45-13.00 | Panel discussion: Innovative IBD Therapies in the Dutch Healthcare System | |
